These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8223753)

  • 1. Beat-to-beat variability of ventricular late potentials in the unaveraged high resolution electrocardiogram--effects of antiarrhythmic drugs.
    Höher M; Axmann J; Eggeling T; Kochs M; Weismüller P; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():33-9. PubMed ID: 8223753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic predictors in the ESVEM trial: unsustained ventricular tachycardia, heart period variability, and the signal-averaged electrocardiogram.
    Anderson KP; Bigger JT; Freedman RA
    Prog Cardiovasc Dis; 1996; 38(6):463-88. PubMed ID: 8638028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Action of sotalol on high-amplification electrocardiogram].
    Brembilla-Perrot B; Houriez P; Preiss JP; Claudon O; Beurrier D; Terrier de la Chaise A; Louis P
    Arch Mal Coeur Vaiss; 2000 Mar; 93(3):271-5. PubMed ID: 11004973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic correlates of spontaneous termination of ventricular tachycardia in patients with coronary artery disease.
    Duff HJ; Mitchell LB; Gillis AM; Sheldon RS; Chudleigh L; Cassidy P; Chiamvimonvat N; Wyse DG
    Circulation; 1993 Sep; 88(3):1054-62. PubMed ID: 8353867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse use dependence of human ventricular repolarization by chronic oral sotalol in monophasic action potential recordings.
    Shimizu W; Kurita T; Suyama K; Aihara N; Kamakura S; Shimomura K
    Am J Cardiol; 1996 May; 77(11):1004-8. PubMed ID: 8644624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive prediction of efficacy of type IA antiarrhythmic drugs by the signal-averaged electrocardiogram in patients with coronary artery disease and sustained ventricular tachycardia.
    Hopson JR; Kienzle MG; Aschoff AM; Shirkey DR
    Am J Cardiol; 1993 Aug; 72(3):288-93. PubMed ID: 8342506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate and time dependent effects of D-sotalol on the monophasic action potential after sudden increase of the heart rate.
    Melichercik J; Brachmann J; Schöls W; Hilbel T; Beyer T; Kübler W
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):65-72. PubMed ID: 9990602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of type I antiarrhythmic drugs on the signal-averaged electrocardiogram in patients with malignant ventricular arrhythmias.
    Greenspon AJ; Kidwell GA; DeCaro M; Hessen S
    Pacing Clin Electrophysiol; 1992 Oct; 15(10 Pt 1):1445-53. PubMed ID: 1383955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antiarrhythmic therapy on delayed potentials detected by the signal-averaged electrocardiogram in patients with ventricular tachycardia after acute myocardial infarction.
    Denniss AR; Ross DL; Richards DA; Cody DV; Russell PA; Young AA; Uther JB
    Am J Cardiol; 1986 Aug; 58(3):261-5. PubMed ID: 3739914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sotalol on the signal-averaged electrocardiogram in patients with sustained ventricular tachycardia: relation to suppression of inducibility and changes in tachycardia cycle length.
    Freedman RA; Karagounis LA; Steinberg JS
    J Am Coll Cardiol; 1992 Nov; 20(5):1213-9. PubMed ID: 1401624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease.
    Sarubbi B; Ducceschi V; Briglia N; Mayer MS; Santangelo L; Iacono A
    Int J Cardiol; 1998 Sep; 66(2):157-64. PubMed ID: 9829329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential action of mexiletine on central common pathway of reentrant ventricular tachycardia.
    Aizawa Y; Abe A; Ohira K; Furushima H; Chinushi M; Fujita S
    J Am Coll Cardiol; 1996 Dec; 28(7):1759-64. PubMed ID: 8962563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
    Aizawa Y; Chinushi M; Naitoh N; Shibata A
    Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
    Goedel-Meinen L; Hofmann M; Schmidt G; Barthel P; Baedeker W; Blömer H
    Herz; 1988 Jun; 13(3):188-96. PubMed ID: 3136064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavior of late potentials on the body surface during programmed ventricular stimulation.
    Ho DS; Daly M; Richards DA; Uther JB; Ross DL
    J Am Coll Cardiol; 1996 Nov; 28(5):1283-91. PubMed ID: 8890828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepant effects of mexiletine on cycle length of ventricular tachycardia and on the effective refractory period in the area of slow conduction.
    Aizawa Y; Chinushi M; Kitazawa H; Washizuka T; Abe A; Shibata A; Kodama I
    Heart; 1996 Mar; 75(3):281-6. PubMed ID: 8800993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Late potentials in dilated cardiomyopathy in relation to ventricular tachycardia and cardiac function: their significance].
    Yamada T; Fukunami M; Ohmori M; Kumagai K; Sakai A; Kondo N; Minamino T; Hoki N
    J Cardiol; 1992; 22(1):91-7. PubMed ID: 1307582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time domain analysis of the signal averaged electrocardiogram in patients with a conduction defect or a bundle branch block.
    Gatzoulis KA; Carlson MD; Biblo LA; Rizos I; Gialafos J; Toutouzas P; Waldo AL
    Eur Heart J; 1995 Dec; 16(12):1912-9. PubMed ID: 8682026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
    Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective prolongation of QRS late potentials by sodium channel blocking antiarrhythmic drugs: relation to slowing of ventricular tachycardia. Electrophysiologic Study Versus Electrocardiographic Monitoring Trial (ESVEM) Investigators.
    Freedman RA; Steinberg JS
    J Am Coll Cardiol; 1991 Apr; 17(5):1017-25. PubMed ID: 1848871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.